Louis Scampavia
Papers
2
Total Citations
52
H-Index
1
About
Louis Scampavia is a leading figure in the development of high-throughput screening (HTS) technologies, with a particular focus on creating affordable, physiologically relevant assays for drug discovery and vector control. His major contributions include pioneering the automation of magnetic 3D spheroid models, which enable more accurate, scalable cell-based assays for early-stage drug screening. This work, highlighted in his 2019 paper with 51 citations, addresses a critical need for cost-effective three-dimensional culture systems that better mimic in vivo conditions. More recently, Scampavia has expanded into public health, designing and validating a high-throughput in vivo platform for the rapid discovery of adult mosquitocides, a scalable solution for vector-borne disease control. His research bridges engineering, biology, and automation, driving innovation in both pharmaceutical and global health applications. With a career marked by translating complex biological models into practical, automated systems, Scampavia’s work continues to influence how researchers approach screening—from cancer therapeutics to mosquito-borne illness prevention.
Research Focus
Key Achievements
Top Papers
- 1
- 2